跳轉至內容
Merck
全部照片(2)

文件

850149P

Avanti

18:1 PI

Avanti Polar Lipids

同義詞:

1,2-二-(9Z-十八烯酰基)-sn-甘油-3-磷酸肌醇(铵盐); DOPI; PI(18:1(9Z)/ 18:1(9Z)); 110659

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C45H86NO13P
CAS號碼:
分子量::
880.14
分類程式碼代碼:
51191904
NACRES:
NA.25

描述

1,2-dioleoyl-sn-glycero-3-phospho-(1′-myo-inositol) (ammonium salt)

化驗

>99% (TLC)

形狀

powder

包裝

pkg of 1 × 100 μg (with stopper and crimp cap (850149P-100ug))
pkg of 1 × 500 μg (with stopper and crimp cap (850149P-500ug))

製造商/商標名

Avanti Polar Lipids

脂質類型

phospholipids
cardiolipins

運輸包裝

dry ice

儲存溫度

−20°C

SMILES 字串

[H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[NH4+]

一般說明

磷脂酰肌醇(PI)是一种磷脂,占真核细胞总脂质的10%。18:1 PI(1,2-二油酰基-sn-甘油-3-磷酸-(1′-肌肌醇)/DOPI)是一种阴离子型磷脂。
肌醇磷脂物质是膜结合的信号分子,它参与细胞生理学的几乎所有方面,包括细胞生长、代谢、增殖和存活。

應用

18:1 PI(1,2-二油酰基-sn-甘油-3-磷酸-(1′-肌肌醇)/DOPI)已用于制备混合脂质巨型单室囊泡(LM-GUV)。

生化/生理作用

磷脂酰肌醇(PI)可作为前体,生成水溶性磷酸肌醇。18:1 PI(1,2-二油酰基-sn-甘油-3-磷酸-(1′-肌肌醇)/DOPI)可作为溶酶体磷脂酶A2(LPLA2)的底物,并促进其活性。

包裝

带塞子和压接盖的2 mL棕色血清瓶(850149P-100ug)
带塞子和压接盖的2 mL棕色血清瓶(850149P-500ug)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

儲存類別代碼

11 - Combustible Solids


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Inositol Phosphate Metabolism
Cellular and Molecular Mechanisms of Inflammation, 153-174 (1992)
Betsy B McIntosh et al.
Current biology : CB, 28(2), 236-248 (2018-01-18)
Microtubule and actin filament molecular motors such as kinesin-1 and myosin-Ic (Myo1c) transport and remodel membrane-bound vesicles; however, it is unclear how they coordinate to accomplish these tasks. We introduced kinesin-1- and Myo1c-bound giant unilamellar vesicles (GUVs) into a micropatterned
Michael Margolis et al.
Biochimie, 108, 133-139 (2014-12-03)
Obesity, an established risk factor for breast cancer (BC), is associated with systemic inflammation. The breast contains adipose tissue (bAT), yet whether it plays a role in BC progression in obese females is being intensively studied. There is scarce knowledge
Natalia Rueda-Rincon et al.
Oncotarget, 6(25), 21240-21254 (2015-06-11)
The p53 tumor suppressor is the central component of a complex network of signaling pathways that protect organisms against the propagation of cells carrying oncogenic mutations. Here we report a previously unrecognized role of p53 in membrane phospholipids composition. By

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務